|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 96923317.0 (espacenet) (Federated) (European Patent Register), 19960617 | | Patent/reg. no. and date | DK/EP 0835110, 20060405 | | Publication date | 19980415 | | Priority no. and date | US 496262, 19950628 | | EP pub. no. and date |
EP 0835110 19980415 | | Effective date | | | Applicant/owner | ALLERGAN, INC., 2525 Dupont Drive
Irvine,
California 92612, US | | Applicant ref. no. | P80600099DK00E | | Inventor | | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/495 (2006.01) | | Title | Anvendelse af (2-imidazolin-2-ylamino)-quinoxaliner til behandling af okulær nerveskade | | Int. application no. | US1996010468 | | Int. publication no. | WO1997001339 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
